Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Unknown 3Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 2Neutropenia 1Central Line-associated Bloodstream Infection (CLABSI) 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × Vascular Access Devices × Clear all
NCT05740150 2023-02-22

CATERPILLAR

Princess Maxima Center for Pediatric Oncology

Phase NA Unknown
462 enrolled

Central Line-associated Bloodstream Infection (CLABSI)

NCT04103021 2019-09-25

Ultrasound Guided Port-A-Cath Isertion in Cancer Patients

Assiut University

Phase NA Unknown
20 enrolled
Tumor-Agnostic

Neoplasms

NCT02967341 2016-11-18

Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients

Universitair Ziekenhuis Brussel

Phase 4 Unknown
15 enrolled

Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡